INS and type 2 diabetes mellitus: Although ketoacidosis can occur in T2D patients not on insulin, a human study has shown that when T2D patients were admitted to hospital with COVID-19, those who were administered SGLT2i therapy were at no greater risk of ketoacidosis than those not taking the inhibitors [72].